Holen Sie sich die Stockscreener-App
10.07
5.80%
-0.62
Finanzdaten der Ars Pharmaceuticals Inc-Aktie (SPRY)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
90.79%
7.973
|
86.58 | 2.068 | 0.50 | - |
Operating Expenses
|
14.64%
45.15
|
39.38 | 23.82 | 15.84 | 13.19 |
| Benefits Costs and Expenses |
100.00%
-
|
80.86 | - | - | - |
| Costs And Expenses |
61.16%
45.15
|
28.02 | 23.82 | 15.84 | 13.19 |
| Depreciation and Amortization |
0.28
|
- | 0.10 | - | - |
| Operating Income/Loss |
178.77%
-37.18
|
47.20 | -21.75 | -15.34 | -13.19 |
| Income/Loss From Continuing Operations Before Tax |
39.44%
7.973
|
5.718 | 2.068 | 0.50 | -10.29 |
| Income/Loss From Continuing Operations After Tax |
167.97%
-33.94
|
49.93 | -19.13 | -12.52 | -10.29 |
|
Net Income/Loss
|
167.97%
-33.94
|
49.93 | -19.13 | -12.52 | -10.29 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
63,641%
98.06
|
0.1538 | 97.03 | 96.83 | 96.49 |
| Diluted Average Shares |
1,649%
98.06
|
5.608 | 97.03 | 96.83 | 96.49 |
| Basic Earnings Per Share |
168.63%
-0.35
|
0.51 | -0.20 | -0.13 | -0.11 |
| Diluted Earnings Per Share |
168.63%
-0.35
|
0.51 | -0.20 | -0.13 | -0.11 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):